Task: Answer the multiple choice question.
Query: Which compound exhibits a 36.391% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] Cc1cnc(NC(=O)Cc2cccs2)s1
[b] CC1(C)OC(=O)N(CC(=O)Nc2ccccc2)C1(C)O
[c] O=C(Oc1ccccc1C(=O)N1CCOCC1)c1ccc(F)cc1
[d] C/C(=N\NC(=O)CC1N=C(Cc2ccccc2)NNC1=O)c1ccc(Br)cc1
Answer: b. CC1(C)OC(=O)N(CC(=O)Nc2ccccc2)C1(C)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C)OC(=O)N(CC(=O)Nc2ccccc2)C1(C)O
CC1(C)OC(=O)N(CC(=O)Nc2ccccc2)C1(C)O
2-(4-hydroxy-4,5,5-trimethyl-2-oxo-1,3-oxazolidin-3-yl)-N-phenylacetamide